A wealth of evidence points to an abnormal form of the prion protein called PrPSc as the transmissible agent responsible for prion diseases. However, the physiological function of its normal conformer, the cellular prion protein (PrPC), is still unknown. Recently, a homologue of PrPC was discovered and denoted Doppel (Dpl). In contrast to PrP, mice deficient for Dpl suffer from an important pathological phenotype: male sterility. This phenotype shifts the attention from the brain, where most of the investigations on Dpl have been performed, to testis, raising hope to resolve the long lasting search of PrPC function.   

1.
Aguzzi A: Between cows and monkeys. Nature 381:734 (1996).
2.
Aguzzi A, Heikenwalder M: Prion diseases: Cannibals and garbage piles. Nature 423:127–129 (2003).
3.
Aguzzi A and Weissmann C: Spongiform encephalopathies: a suspicious signature. Nature 383:666–667 (1996).
4.
Behrens A, Aguzzi A: Small is not beautiful: antagonizing functions for the prion protein PrP(C) and its homologue Dpl. Trends Neurosci 25:150–154 (2002).
5.
Behrens A, Brandner S, Genoud N, Aguzzi A: Normal neurogenesis and scrapie pathogenesis in neural grafts lacking the prion protein homologue Doppel. EMBO Rep 2:347–352 (2001).
6.
Behrens A, Genoud N, Naumann H, Rulicke T, Janett F, Heppner FL, Ledermann B, Aguzzi A: Absence of the prion protein homologue Doppel causes male sterility. EMBO J 21:3652–3658 (2002).
7.
Bounhar Y, Zhang Y, Goodyer, CG, LeBlanc A: Prion protein protects human neurons against Bax-mediated apoptosis. J biol Chem 276:39145–39149 (2001).
8.
Brinster RL: Germline stem cell transplantation and transgenesis. Science 296:2174–2176 (2002).
9.
Bruce ME, Will RG, Ironside JW, McConnell I, Drummond D, Suttie A, McCardle L, Chree A, Hope J, Birkett, C, Cousens S, Fraser H, Bostock CJ: Transmissions to mice indicate that “new variant” CJD is caused by the BSE agent. Nature 389:498–501 (1997).
10.
Büeler HR, Aguzzi A, Sailer A, Greiner RA, Autenried P, Aguet M, Weissmann C: Mice devoid of PrP are resistant to scrapie. Cell 73:1339–1347 (1993).
11.
Büeler HR, Fischer M, Lang Y, Bluethmann H, Lipp HP, DeArmond SJ, Prusiner SB, Aguet M, Weissmann C: Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature 356:577–582 (1992).
12.
Collinge J, Sidle KC, Meads J, Ironside J, Hill AF: Molecular analysis of prion strain variation and the aetiology of “new variant” CJD. Nature 383:685–690 (1996).
13.
Flechsig E, Shmerling D, Hegyi I, Raeber AJ, Fischer M, Cozzio A, von Mering C, Aguzzi A, Weissmann C: Prion protein devoid of the octapeptide repeat region restores susceptibility to scrapie in PrP knockout mice. Neuron 27:399–408 (2000).
14.
Ford MJ, Burton LJ, Morris RJ, Hall SM: Selective expression of prion protein in peripheral tissues of the adult mouse. Neuroscience 113:177–192 (2002).
15.
Gauczynski S, Peyrin JM, Haik S, Leucht C, Hundt C, Rieger R, Krasemann S, Deslys JP, Dormont D, Lasmezas CI, Weiss S: The 37-kDa/67-kDa laminin receptor acts as the cell-surface receptor for the cellular prion protein. EMBO J 20:5863–5875 (2001).
16.
Glatzel M, Heppner FL, Albers KM, Aguzzi A: Sympathetic innervation of lymphoreticular organs is rate limiting for prion neuroinvasion. Neuron 31:25–34 (2001).
17.
Herault Y, Rassoulzadegan M, Cuzin F, Duboule D: Engineering chromosomes in mice through targeted meiotic recombination (TAMERE). Nat Genet 20:381–384 (1998).
18.
Hill AF, Desbruslais M, Joiner S, Sidle KC, Gowland I, Collinge J, Doey LJ, Lantos P: The same prion strain causes vCJD and BSE. Nature 389:448–450 (1997).
19.
Ikawa M, Tergaonkar V, Ogura A, Ogonuki N, Inoue K, Verma IM: Restoration of spermatogenesis by lentiviral gene transfer: offspring from infertile mice. Proc natl Acad Sci USA 99:7524–7529 (2002).
20.
Keshet GI, Bar-Peled O, Yaffe D, Nudel U, Gabizon R: The cellular prion protein colocalizes with the dystroglycan complex in the brain. J Neurochem 75:1889–1897 (2000).
21.
Kurschner C, Morgan JI: The cellular prion protein (PrP) selectively binds to Bcl-2 in the yeast two-hybrid system. Brain Res 30:165–168 (1995).
22.
Li A, Sakaguchi S, Shigematsu K, Atarashi R, Roy BC, Nakaoke R, Arima K, Okimura N, Kopacek J, Katamine S: Physiological expression of the gene for PrP-like protein, PrPLP/Dpl, by brain endothelial cells and its ectopic expression in neurons of PrP- deficient mice ataxic due to purkinje cell degeneration [In Process Citation]. Am J Pathol 157:1447–1452 (2000).
23.
Lu K, Wang W, Xie Z, Won, BS, Li R, Petersen RB, Sy MS, Chen SG: Expression and structural characterization of the recombinant human doppel protein. Biochemistry 39:13575–13583 (2000).
24.
Luhrs T, Riek R, Guntert P, Wuthrich K: NMR structure of the human doppel protein. J Mol Biol 326:1549–1557 (2003).
25.
Mallucci GR, Ratte S, Asante EA, Linehan J, Gowland I, Jefferys JG, Collinge J: Post-natal knockout of prion protein alters hippocampal CA1 properties, but does not result in neurodegeneration. EMBO J 21:202–210 (2002).
26.
Mastrangelo P, Serpell L, Dafforn T, Lesk A, Fraser P, Westaway D: A cluster of familial Creutzfeldt-Jakob disease mutations recapitulate conserved residues in Doppel: a case of molecular mimicry? FEBS Lett 532:21–26 (2002).
27.
Mead S, Beck J, Dickinson A, Fisher EM, Collinge J: Examination of the human prion protein-like gene doppel for genetic susceptibility to sporadic and variant Creutzfeldt-Jakob disease. Neurosci Lett 290:117–120 (2000).
28.
Mo H, Moore RC, Cohen FE, Westaway D, Prusiner SB, Wright PE, Dyson HJ: Two different neurodegenerative diseases caused by proteins with similar structures. Proc natl Acad Sci USA 98:2352–2357 (2001).
29.
Montrasio F, Frigg R, Glatzel M, Klein MA, Mackay F, Aguzzi A, Weissmann C: Impaired prion replication in spleens of mice lacking functional follicular dendritic cells. Science 288:1257–1259 (2000).
30.
Peoc’h K, Guerin C, Brandel JP, Launay JM, Laplanche JL: First report of polymorphisms in the prion-like protein gene (PRND): implications for human prion diseases. Neurosci Lett 286:144–148 (2000).
31.
Peoc’h K, Serres C, Frobert Y, Martin C, Lehmann S, Chasseigneaux S, Sazdovitch V, Grassi J, Jouannet P, Launay JM, Laplanche JL: The human “prion-like” protein Doppel is expressed in both Sertoli cells and spermatozoa. J biol Chem 277:43071–43078 (2002).
32.
Prusiner SB: Novel proteinaceous infectious particles cause scrapie. Science 216:136–144 (1982).
33.
Prusiner SB: Molecular biology of prion diseases. Science 252:1515–1522 (1991).
34.
Schmitt-Ulms G, Legname G, Baldwin MA, Ball HL, Bradon N, Bosque PJ, Crossin KL, Edelman GM, DeArmond SJ, Cohen FE, Prusiner SB: Binding of neural cell adhesion molecules (N-CAMs) to the cellular prion protein. J Mol Biol 314:1209–1225 (2001).
35.
Shaked Y, Rosenmann H, Talmor G, Gabizon R: A C-terminal-truncated PrP isoform is present in mature sperm. J biol Chem 274:32153–32158 (1999).
36.
Silverman GL, Qin K, Moore RC, Yang Y, Mastrangelo P, Tremblay P, Prusiner SB, Cohen FE, Westaway D: Doppel is an N-glycosylated, glycosylphosphatidylinositol-anchored protein. Expression in testis and ectopic production in the brains of Prnp(0/0) mice predisposed to Purkinje cell loss. J biol Chem 275:26834–26841 (2000).
37.
Tuzi NL, Gall E, Melton D,Manson, JC: Expression of doppel in the CNS of mice does not modulate transmissible spongiform encephalopathy disease. J Gen Virol 83:705–711 (2002).
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.